Article Text

Download PDFPDF
MRI of the wrist in early rheumatoid arthritis
  1. C G Peterfy
  1. Correspondence to:
    Dr C G Peterfy
    Synarc Inc, 575 Market Street, 17th Floor, San Francisco 94105, CA, USA;

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Can it be used to predict long term functional outcome?

The past several years have witnessed unprecedented advances in rheumatology, with the introduction of several new compounds capable of halting the relentless progression of joint destruction and functional disability in patients with rheumatoid arthritis (RA). With these successes, however, have come new pressures for medical imaging to resolve even the slightest traces of erosive joint damage and to identify pre-erosive inflammatory features that can accurately predict which patients will go on to severe functional debility if they do not receive aggressive structure modifying treatment immediately.


Before the introduction of effective treatment, rheumatology’s demand for imaging joint structure was modest, at best (fig 1). Although it was widely accepted that joint damage was a key driver of functional disability in RA, particularly in late disease,1–3 without effective treatments to prevent erosive destruction, there was limited need for detailed information about the integrity of joint structure. Magnetic resonance imaging (MRI) promised to tell more about bone erosion, synovitis, and the integrity of cartilage, ligaments and other articular tissues than radiography ever could, but the additional cost and inconveniences associated with MRI were not felt to be worth the extra performance. The information simply did not impact on clinical management. Accordingly, most rheumatologists focused primarily on clinical and laboratory features of the disease, and used imaging only sparingly—if at all. Not surprisingly, the development of MRI for this purpose languished. However, the recent introduction of effective structure modifying treatments has changed the way that rheumatologists manage patients with RA, and this has created new demands on imaging both in clinical practice and in clinical research.

Figure 1

Technical demand-performance relationships for radiography and MRI in RA. (A) Before the availability of effective structure modifying treatment, clinical rheumatology’s demand for technical performance in imaging …

View Full Text